X0306 4 2017-11-21 0 0001604950 scPharmaceuticals Inc. SCPH 0001722234 Agger Mette Kirstine C/O SCPHARMACEUTICALS INC 2400 DISTRICT AVENUE, SUITE 310 BURLINGTON MA 01830 1 0 0 0 Common Stock 2017-11-21 4 C 0 1544858 A 1544858 I By: Lundbeckfond Invest A/S Common Stock 2017-11-21 4 C 0 984366 A 2529224 I By: Lundbeckfond Invest A/S Series A Preferred Stock 2017-11-21 4 C 0 11092383 0.00 D Common Stock 1544858 0 I By: Lundbeckfond Invest A/S Series B Preferred Stock 2017-11-21 4 C 0 7067945 0.00 D Common Stock 984366 0 I By: Lundbeckfond Invest A/S Represents the total number of shares of Common Stock received by Lundbeckfond Invest A/S ("LIAS"), upon conversion of the Issuer's Series A Preferred Stock in connection with the closing of the Issuer's initial public offering. These shares are directly held by LIAS. The Reporting Person is the Managing Partner at Lundbeckfonden Ventures, which is the General Partner of LIAS. The reporting person disclaims beneficial ownership of such shares except to the extent of her pecuniary interest, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of all of the reported shares for purposes of Section 16 or any other purpose. Represents the total number of shares of Common stock received by Lundbeckfond Invest A/S ("LIAS"), upon conversion of the Issuer's Series B Preferred Stock in connection with the closing of the Issuer's initial public offering. All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 7.180193-for-1 basis on November 21, 2017 and had no expiration date. /s/ Courtney Gaughan, Attorney-in-Fact 2017-11-21